(19)
(11) EP 0 772 680 A1

(12)

(43) Date of publication:
14.05.1997 Bulletin 1997/20

(21) Application number: 95926736.0

(22) Date of filing: 18.07.1995
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 48/ 00( . )
A61P 31/ 22( . )
C07K 14/ 035( . )
C12N 15/ 38( . )
A61K 39/ 245( . )
A61P 31/ 12( . )
C07H 21/ 04( . )
C12N 15/ 00( . )
C12R 1/ 92( . )
(86) International application number:
PCT/US1995/009057
(87) International publication number:
WO 1996/003510 (08.02.1996 Gazette 1996/07)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30) Priority: 22.07.1994 US 19940279459

(71) Applicant: Merck & Co., Inc.
Rahway New Jersey 07065-0900 (US)

(72) Inventors:
  • ARMSTRONG, Marcy, E.
    Rahway, NJ 07065 (US)
  • KEYS, Robert, D.
    Rahway, NJ 07065 (US)
  • LEWIS, John, A.
    Rahway, NJ 07065 (US)
  • LIU, Margaret, A.
    Rahway, NJ 07065 (US)
  • McCLEMENTS, William, L.
    Rahway, NJ 07065 (US)

(74) Representative: Thompson, John Dr., et al 
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) A POLYNUCLEOTIDE HERPES VIRUS VACCINE